Watson Reaches New 52-Week High (WPI)

NEW YORK ( TheStreet) -- Watson Pharmaceuticals (NYSE: WPI) hit a new 52-week high Thursday as it is currently trading at $75, above its previous 52-week high of $73.35 with 1.5 million shares traded as of 9:35 a.m. ET. Average volume has been 1.9 million shares over the past 30 days.

Watson has a market cap of $8.75 billion and is part of the health care sector and drugs industry. Shares are up 13.7% year to date as of the close of trading on Wednesday.

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products in the United States, western Europe, Canada, Australasia, Asia, South America, and South Africa. The company has a P/E ratio of 33.3, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Watson as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Watson Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Watson Rises On Unusually High Volume (WPI)

Watson Rises On Unusually High Volume (WPI)

5 Drugs Stocks On The Rise

5 Drugs Stocks On The Rise

Watson Stock Hits New 52-Week High (WPI)

Watson Stock Hits New 52-Week High (WPI)

Watson Rises On Unusually High Volume (WPI)

Watson Rises On Unusually High Volume (WPI)

Watson Reaches New 52-Week High (WPI)

Watson Reaches New 52-Week High (WPI)